Models of West Nile virus disease

Drug Discovery Today: Disease Models

Volumn 3, Issue 1, 2006, Pages 49-54

  Ben Nathan, David ^a   Porgador, Angel ^b   Yavelsky, Victoria ^b   Rager Zisman, Bracha ^b  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHIMERIVAX; DNA VACCINE; IMMUNOGLOBULIN G; OMR IGG AM; PEPTIDE INHIBITOR; SERINE PROTEINASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; WEST NILE VACCINE;

ANIMAL MODEL; BLOOD TRANSFUSION; CLINICAL TRIAL; COMPUTER MODEL; CROW; DISEASE MODEL; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; GENETIC ANALYSIS; GEOGRAPHIC DISTRIBUTION; GOOSE; HAMSTER; HORSE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MONKEY; MOSQUITO; MOUSE STRAIN; NONHUMAN; NORTH AMERICA; ORGAN TRANSPLANTATION; PATHOGENESIS; PREDICTION; REVIEW; TICK; VIRUS INFECTION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE; WEST NILE FLAVIVIRUS;

EID: 33645857049     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.03.004     Document Type: Review

References (20)

1. Hall R.A., and Khromykh A.A. West Nile virus vaccines. Expert Opin. Biol. Ther. 4 (2004) 1295-1305
2. Diamond M.S. Development of effective therapies against West Nile virus infection. Expert Rev. Anti-Infect. Ther. 3 (2005) 931-944
3. Sbrana E., et al. Oral transmission of West Nile virus in a hamster model. Am. J. Trop. Med. Hyg. 72 (2005) 325-329
4. Brinton M.A. Isolation of a replication-efficient mutant of West Nile virus from a persistently infected genetically resistant mouse cell culture. J. Virol. 39 (1981) 413-421
5. Halevy M., et al. Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID mice. Arch. Virol. 137 (1994) 355-370
6. Pletnev A.G., et al. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc. Natl. Acad. Sci. U S A 99 (2002) 3036-3041
7. Shi P.Y., et al. Infectious cDNA clone of the epidemic West Nile virus from New York City. J. Virol. 76 (2002) 5847-5856
8. Chu J.J., and Ng M.L. The mechanism of cell death during West Nile virus infection is dependent on initial infectious dose. J. Gen. Virol. 84 Pt. 12 (2003) 3305-3314
9. Shrestha B., et al. Infection and injury of neurons by West Nile encephalitis virus. J. Virol. 77 (2003) 13203-13213
10. Lo M.K., et al. Potential high-throughput assay for screening inhibitors of West Nile virus replication. J. Virol. 77 (2003) 12901-12906
11. Holmes D.A., et al. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections. J. Clin. Microbiol. 43 (2005) 3227-3236
12. Scholle F., et al. Trans-packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J. Virol. 78 (2004) 11605-11614
13. Lucas M., et al. The Israeli strain IS-98-ST1 of West Nile virus as viral model for West Nile encephalitis in the Old World. Virol. J. 1 (2004) 9
14. Ben-Nathan D., et al. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J. Infect. Dis. 188 (2003) 5-12
15. Ratterree M.S., et al. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J. Infect. Dis. 189 (2004) 669-676
16. Johnson B.W., et al. Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes. Med. Vet. Entomol. 17 (2003) 235-243
17. Vijayasri S., and Agrawal S. Domain-based homology modeling and mapping of the conformational epitopes of envelope glycoprotein of West Nile virus. J. Mol. Model. (Online) 11 (2005) 248-255
18. Mukhopadhyay S., et al. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3 (2005) 13-22
19. Ganesh V.K., et al. Identification and characterization of nonsubstrate based inhibitors of the essential dengue and West Nile virus proteases. Bioorg. Med. Chem. 13 (2005) 257-264
20. Mukhopadhyay S., et al. Structure of West Nile virus. Science 302 (2003) 248